Ikarian Capital’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $6.57M | Sell |
469,949
-25,000
| -5% | -$350K | 1.26% | 16 |
|
2025
Q1 | $6.67M | Buy |
494,949
+25,000
| +5% | +$337K | 0.82% | 14 |
|
2024
Q4 | $9.01M | Sell |
469,949
-30,028
| -6% | -$576K | 1.23% | 6 |
|
2024
Q3 | $11.4M | Buy |
+499,977
| New | +$11.4M | 1.59% | 5 |
|
2024
Q2 | – | Hold |
0
| – | – | – | 110 |
|
2024
Q1 | – | Hold |
0
| – | – | – | 118 |
|
2022
Q3 | – | Hold |
0
| – | – | – | 119 |
|
2022
Q2 | – | Hold |
0
| – | – | – | 161 |
|